Numaferm News

16 August 2023

Numaferm x Labiotech – Podcast

For the “lazy” readers amongst us, a great chance to learn more about pepteins, how they are produced at Numaferm and how we help our […]

Read more
06 July 2023

Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides

Numaferm, a Germany-based biotech company, specialized in the production of pepteins, and Zoetis, the global leading animal health company, have signed a licensing agreement for […]

Read more
22 May 2023

ISO 9001:2015 Re-Certification

After the successful TÜV audit, we have been re-certified, fulfilling all requirements according to DIN EN ISO 9001:2015.

Read more
10 May 2023

PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs

Baar (Switzerland) and Düsseldorf (Germany), 9 May 2023 – PolyPeptide, a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs), and Numaferm, a […]

Read more